These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 7846895)

  • 1. [Lipid metabolism and insulin resistance--clinical aspects and pathobiochemistry].
    Gries FA; Hübinger A
    Wien Klin Wochenschr; 1994; 106(24):763-7. PubMed ID: 7846895
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacodynamic effects of oral contraceptive steroids on biochemical markers for arterial thrombosis. Studies in non-diabetic women and in women with insulin-dependent diabetes mellitus.
    Petersen KR
    Dan Med Bull; 2002 Feb; 49(1):43-60. PubMed ID: 11894723
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Dyslipoproteinemia and metabolic syndrome. Effects of insulin resistance and hyperinsulinemia on lipid metabolism].
    Krone W; Müller-Wieland D; Wirth H
    Fortschr Med; 1992 Dec; 110(34):645-8. PubMed ID: 1483617
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Metabolic syndrome--bridge to type II diabetes].
    Häring HU
    Z Gesamte Inn Med; 1993 Mar; 48(3):108-11. PubMed ID: 8475632
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Hypertension in metabolic syndrome. Etiology and consequences].
    Rett K
    Fortschr Med; 1992 Dec; 110(34):642-4. PubMed ID: 1483616
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The metabolic syndrome. Pathophysiologic causes, diagnosis, therapy].
    Rett K; Wicklmayr M; Standl E
    Wien Klin Wochenschr; 1994; 106(24):750-7. PubMed ID: 7846893
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Insulin resistance and cardiovascular complications].
    Janka HU
    Wien Klin Wochenschr; 1994; 106(24):758-62. PubMed ID: 7846894
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential effects of n-3 polyunsaturated fatty acids on metabolic control and vascular reactivity in the type 2 diabetic ob/ob mouse.
    Mustad VA; Demichele S; Huang YS; Mika A; Lubbers N; Berthiaume N; Polakowski J; Zinker B
    Metabolism; 2006 Oct; 55(10):1365-74. PubMed ID: 16979408
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin sensitivity indices of glucose and free fatty acid metabolism in obese children and adolescents in relation to serum lipids.
    Reinehr T; Kiess W; Andler W
    Metabolism; 2005 Mar; 54(3):397-402. PubMed ID: 15736120
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is postprandial hypertriglyceridaemia in relatives of type 2 diabetic subjects a consequence of insulin resistance?
    Kriketos A; Milner KL; Denyer G; Campbell L
    Eur J Clin Invest; 2005 Feb; 35(2):117-25. PubMed ID: 15667583
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Insulin resistance--a physiopathological condition with numerous sequelae: non-insulin-dependent diabetes mellitus (NIDDM), android obesity, essential hypertension, dyslipidemia and atherosclerosis].
    Pedersen O
    Ugeskr Laeger; 1992 May; 154(20):1411-8. PubMed ID: 1631967
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of lipids in the pathogenesis of muscle insulin resistance and beta cell failure in type II diabetes and obesity.
    Kraegen EW; Cooney GJ; Ye JM; Thompson AL; Furler SM
    Exp Clin Endocrinol Diabetes; 2001; 109 Suppl 2():S189-201. PubMed ID: 11460570
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of plasma free fatty acids on lipoprotein synthesis and diabetic dyslipidemia.
    Julius U
    Exp Clin Endocrinol Diabetes; 2003 Aug; 111(5):246-50. PubMed ID: 12951628
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulin resistance--a common link between type 2 diabetes and cardiovascular disease.
    Lebovitz HE
    Diabetes Obes Metab; 2006 May; 8(3):237-49. PubMed ID: 16634983
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fatty acids and insulin resistance in muscle and liver.
    Kovacs P; Stumvoll M
    Best Pract Res Clin Endocrinol Metab; 2005 Dec; 19(4):625-35. PubMed ID: 16311221
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent advances in the relationship between obesity, inflammation, and insulin resistance.
    Bastard JP; Maachi M; Lagathu C; Kim MJ; Caron M; Vidal H; Capeau J; Feve B
    Eur Cytokine Netw; 2006 Mar; 17(1):4-12. PubMed ID: 16613757
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Short-term effect of buformin, a biguanide, on insulin sensitivity, soluble fraction of tumor necrosis factor receptor and serum lipids in overweight patients with type 2 diabetes mellitus.
    Ohara S; Komatsu R; Matsuyama T
    Diabetes Res Clin Pract; 2004 Nov; 66(2):133-8. PubMed ID: 15533580
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Postprandial chylomicrons and adipose tissue lipoprotein lipase are altered in type 2 diabetes independently of obesity and whole-body insulin resistance.
    Annuzzi G; Giacco R; Patti L; Di Marino L; De Natale C; Costabile G; Marra M; Santangelo C; Masella R; Rivellese AA
    Nutr Metab Cardiovasc Dis; 2008 Oct; 18(8):531-8. PubMed ID: 18321693
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic syndrome' in a middle-aged Finnish population.
    Vanhala MJ; Kumpusalo EA; Pitkäjärvi TK; Takala JK
    J Cardiovasc Risk; 1997 Aug; 4(4):291-5. PubMed ID: 9477208
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IRIS II study: the IRIS II score--assessment of a new clinical algorithm for the classification of insulin resistance in patients with Type 2 diabetes.
    Forst T; Standl E; Hohberg C; Konrad T; Schulze J; Strotmann HJ; Lübben G; Pahler S; Bachinger A; Langenfeld M; Pfützner A
    Diabet Med; 2004 Oct; 21(10):1149-53. PubMed ID: 15384965
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.